Common Antidepressant Eases Fatigue Associated with Long COVID, Study Finds
Hamilton, ON, Apr 3: A global research team co-led by McMaster University has identified one of the first medications shown to significantly reduce fatigue in people living with Long COVID—marking a major breakthrough for millions affected by persistent post-pandemic symptoms. The randomized, placebo-controlled clinical trial found that Fluvoxamine, a widely available and low-cost antidepressant, significantly […]
Common Antidepressant Eases Fatigue Associated with Long COVID, Study Finds Read More »
